Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244

The rise of antimicrobial-resistant bacterial infections is a crucial health concern in the 21st century. In particular, antibiotic-resistant Pseudomonas aeruginosa causes difficult-to-treat infections associated with high morbidity and mortality. Unfortunately, the number of effective therapeutic i...

Descripción completa

Detalles Bibliográficos
Autores principales: Horspool, Alexander M., Sen-Kilic, Emel, Malkowski, Aaron C., Breslow, Scott L., Mateu-Borras, Margalida, Hudson, Matthew S., Nunley, Mason A., Elliott, Sean, Ray, Krishanu, Snyder, Greg A., Miller, Sarah Jo, Kang, Jason, Blackwood, Catherine B., Weaver, Kelly L., Witt, William T., Huckaby, Annalisa B., Pyles, Gage M., Clark, Tammy, Al Qatarneh, Saif, Lewis, George K., Damron, F. Heath, Barbier, Mariette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140502/
https://www.ncbi.nlm.nih.gov/pubmed/37124031
http://dx.doi.org/10.3389/fcimb.2023.1117844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140502/
https://www.ncbi.nlm.nih.gov/pubmed/37124031
http://dx.doi.org/10.3389/fcimb.2023.1117844

Ejemplares similares